Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
about
Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysisThe strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicityAn imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response.Imaging tumour-bearing animals using clinical scanners.Factors influencing brown fat activation in FDG PET/CT: a retrospective analysis of 15,000+ cases.Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells.
P2860
Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
@ast
Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
@en
type
label
Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
@ast
Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
@en
prefLabel
Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
@ast
Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
@en
P356
P1476
Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
@en
P2093
P356
10.1053/SRAO.2001.18100
P577
2001-01-01T00:00:00Z